Both in Biotechnology
AIM ImmunoTech vs Creative Medical Technology Holdings
Over the past year AIM returned −93.7% and CELZ returned −70.8%; their daily moves had a correlation of 0.04.
AIM −93.7% CELZ −70.8%Growth of $1, one year, split-adjusted
| Metric | AIM | CELZ |
|---|---|---|
| Price | $0.1735 | $0.9652 |
| Market cap | $6.8M | $7.3M |
| Today | −5.91% | −4.44% |
| 1 month | −32.9% | −15.3% |
| 6 months | −68.5% | −50.2% |
| Year to date | −84.6% | −50.8% |
| 1 year | −93.5% | −70.8% |
| Revenue growth (YoY) | +4.0% | — |
| Gross margin | 80.8% | — |
| Net margin | −26876.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 71.6× | 2,442.8× |
| Net cash | $6.3M | $8.7M |
| Dividend yield | — | — |
| Volatility (60d) | 72.3% | 150.0% |
| Short % of float | 10.1% | 2.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).